Found: 5
Select item for more details and to access through your institution.
Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 5, p. 345, doi. 10.1177/1753465811410100
- By:
- Publication type:
- Article
Is the patient’s baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?
- Published in:
- Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 5, p. 289, doi. 10.1177/1753465811407236
- By:
- Publication type:
- Article
Cyclophosphamide-refractory scleroderma-associated interstitial lung disease: remarkable clinical and radiological response to a single course of rituximab combined with high-dose corticosteroids.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 5, p. 299, doi. 10.1177/1753465811407786
- By:
- Publication type:
- Article
The role of sphingolipids in respiratory disease.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 5, p. 325, doi. 10.1177/1753465811406772
- By:
- Publication type:
- Article
Management of fungal lung disease in the immunocompromised.
- Published in:
- Therapeutic Advances in Respiratory Disease, 2011, v. 5, n. 5, p. 305, doi. 10.1177/1753465811398720
- By:
- Publication type:
- Article